A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is an open‐label study being conducted in healthy adults, to learn what happens tothe study medicine (camlipixant) they are receiving in a person's body over time (apharmacokinetic [PK] study). The goal of the study is to understand how the bodyprocesses camlipixant, to check its safety and how well it is tolerated. Participantswill receive camlipixant at different dose levels with different formulation types eitheron an empty stomach or after a meal.
Epistemonikos ID: 47841efe5326390c4c8e4c6cb727b8076b40435a
First added on: Jul 07, 2026